Harvard Health Letter

Has the new sexual desire drug panned out?

During the initial months of availability for flibanserin (Addyi), the first medication for sexual desire disorders, there was not a big demand for the drug. Doctors say this may be due to the fact that the drug has a steep price tag and severe potential side effects, including very low blood pressure, fainting, and nausea. These risks become greater if a woman drinks alcohol or takes birth control pills. There are also strict rules for prescribing and dispensing the drug. 
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »